Kynam Capital Management »

Burning Rock Biotech Ltd- shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Burning Rock Biotech Ltd- (BNR) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Burning Rock Biotech Ltd-

Tip: Access up to 7 years of quarterly data

All positions including Burning Rock Biotech Ltd- held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Burning Rock Biotech Ltd- by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.3M 975k 6.45

More positions owned by Kynam Capital Management

Natera (NTRA)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dynavax Technologies Corp Com New (DVAX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 Call Option (INSM)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
BioCryst Pharmaceuticals (BCRX)
Protagonist Therapeutics (PTGX)
2seventy Bio Common Stock (TSVT)
Miragen Therapeutics (VRDN)
Wave Life Sciences SHS (WVE)

View all positions for Kynam Capital Management

Top funds holding Burning Rock Biotech Ltd-

Kynam Capital Management
Massachusetts Financial Services
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Renaissance Technologies
Bank of America Corporation
Morgan Stanley
SkyView Investment Advisors
Shen Neil Nanpeng
Rhumbline Advisers
Tower Research Capital
Jpmorgan Chase & Co
Ronald Blue Trust
BlackRock
BlackRock

View all funds holding Burning Rock Biotech Ltd-